Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
Open-market buys, last 90 days
$392,144
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-01-24 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +13,280 13,280
2019-01-24 McDonough Cameron Geoffrey Director Grant or award · Stock Option (Right to Buy) +11,804 11,804
2019-01-22 McVeigh Brian Chief Business Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2019-01-22 Hatfield Jeffrey S. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +525,000 525,000
2019-01-22 KIM DENNIS D Chief Medical Officer Grant or award · Stock Option (Right to Buy) +95,000 95,000
2019-01-22 Allen Patricia L Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2018-06-29 Atlas Venture Fund VII L P 10% owner Other disposition −1,126,546 3,506,184
2018-06-29 Atlas Venture Fund VII L P 10% owner Other disposition −234,321 11
2018-06-28 Hughes Thomas E. See Remarks Sale −32,000 $10.00 $320K 125,247
2018-06-06 THOMAS FRANK E Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-06-06 EVERETT WENDY Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-06-06 EVERETT WENDY Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2018-06-06 Barrett Peter Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-06-06 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-06-06 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-06-06 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-06-06 McDonough Cameron Geoffrey Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2018-05-29 McVeigh Brian Chief Business Officer Grant or award · Stock Option (Right to Buy) +225,000 225,000
2018-03-07 Hughes Thomas E. See Remarks Sale −5,000 $10.00 $50K 157,247
2018-02-22 KIM DENNIS D Chief Medical Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000

Page 8 of 15 · 296 trades